Approval · Notice of Compliance 224 · 2003
QVAR: Notice of Compliance 224
Issued April 25, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 224
- Date
- April 25, 2003
- Company
- 3M Pharmaceuticals, A Division Of 3M Canada CompanyLondon, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: prophylactic management of steroid-responsive bronchial asthma in pediatric patients between 5 an 11 years old
- Therapeutic class
- Corticosteroid for oral inhalation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QVAR | Not yet assigned | — |
Medicinal ingredients
- BECLOMETHASONE DIPROPIONATE 50 MCG per ACT
- BECLOMETHASONE DIPROPIONATE 100 MCG per ACT